Skip to content
Open access · CC-BY via OpenAlex

Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior

Hui Li, Xiang Ding, Robert Terkeltaub, Hang Lin, Yuqing Zhang, Bin Zhou, Ke He, Kun Li, Zhichen Liu, Jie Wei, Yuanheng Yang, Hui Xie, Chao Zeng, Guanghua Lei

Arthritis Research & Therapy · 2020 · ▲ 91 citations

Abstract

BACKGROUND: Metformin could activate adenosine monophosphate-activated protein kinase (AMPK) which was postulated as a potential therapeutic target for osteoarthritis. This study aimed to examine the effects of metformin on cartilage and pain in osteoarthritis mouse model. METHODS: Eighty 10-week-old male C57BL/6 mice were randomized to 6 groups: non-operation, sham-operation, destabilization of the medial meniscus (DMM)-operation with intragastric saline/metformin, and DMM-operation with intraarticular saline/metformin. Articular cartilage degeneration was examined by scanning electron microscopy (SEM) and graded using the scoring system recommended by Osteoarthritis Research Society International (OARSI). Mechanical withdrawal threshold and hind paw weight distribution were measured to assess the pain-related behavior. Cell Counting Kit-8 assay, quantificational real-time polymerase chain reaction, and western blot analysis were conducted to examine the anabolic and anti-catabolic effect of metformin and the role of AMPK in mediating its effects on interleukin-1β stimulated primary mice chondrocytes. RESULTS: Compared with mice receiving intragastric and intraarticular saline, mice in both intragastric and intraarticular metformin displayed attenuated articular cartilage degeneration, indicated by less cartilage damage under SEM and significantly lower OARSI scores. A higher paw withdrawal threshold and a decreased weight-bearing asymmetry were observed in the intragastric and intraarticular metformin mice compared with their corresponding saline groups in DMM model of osteoarthritis. In vitro experiments showed that metformin not only decreased the level of matrix metalloproteinase 13, but also elevated type II collagen production through activating AMPK pathway. CONCLUSIONS: Metformin attenuates osteoarthritis structural worsening and modulates pain, suggesting its potential for osteoarthritis prevention or treatment.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1186/s13075-020-2129-y
Canonical
link ↗
Fetched
2026-06-14 MST

Cite this

APA
Li, H., Ding, X., Terkeltaub, R., Lin, H., Zhang, Y., Zhou, B., He, K., Li, K., Liu, Z., Wei, J., Yang, Y., Xie, H., Zeng, C., &amp; Lei, G. (2020). Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior. <em>Arthritis Research & Therapy</em>. https://doi.org/10.1186/s13075-020-2129-y
Vancouver
Li H, Ding X, Terkeltaub R, Lin H, Zhang Y, Zhou B, et al. Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior. Arthritis Research & Therapy. 2020. doi:10.1186/s13075-020-2129-y.
BibTeX
@article{hui2020Explor, title = {Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior}, author = {Hui Li and Xiang Ding and Robert Terkeltaub and Hang Lin and Yuqing Zhang and Bin Zhou and Ke He and Kun Li and Zhichen Liu and Jie Wei and Yuanheng Yang and Hui Xie and Chao Zeng and Guanghua Lei}, journal = {Arthritis Research & Therapy}, year = {2020}, doi = {10.1186/s13075-020-2129-y}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings